Targeted deletion of MKK4 in cancer cells: a detrimental phenotype manifests as decreased experimental metastasis and suggests a counterweight to the evolution of tumor-suppressor loss.
about
Adeno-associated virus vector integrationDownregulation of phosphorylated MKK4 is associated with a poor prognosis in colorectal cancer patients.Mitogen-activated protein kinase kinase 4 (MAP2K4) promotes human prostate cancer metastasis.The mitogen-activated protein kinase kinase 4 has a pro-oncogenic role in skin cancer.MEK and the inhibitors: from bench to bedside.The soft underbelly of tumor cells.Targeting cancer by binding iron: Dissecting cellular signaling pathwaysAssociation between functional polymorphisms in genes involved in the MAPK signaling pathways and cutaneous melanoma riskAAV-mediated gene targeting methods for human cellsMEK4 function, genistein treatment, and invasion of human prostate cancer cellsGenomic and oncogenic preference of HBV integration in hepatocellular carcinoma.Regulation of the metastasis suppressor gene MKK4 in ovarian cancer.Exploring the function of the JNK (c-Jun N-terminal kinase) signalling pathway in physiological and pathological processes to design novel therapeutic strategies.MKK4 as oncogene or tumor suppressor: in cancer and senescence, the story's getting old.Identification of common variants in BRCA2 and MAP2K4 for susceptibility to sporadic pancreatic cancer.A Chemical Probe Strategy for Interrogating Inhibitor Selectivity Across the MEK Kinase Family.Functional variant (-1304T>G) in the MKK4 promoter is associated with decreased risk of acute myeloid leukemia in a southern Chinese population.
P2860
Q24624120-48148CBD-52DA-45F2-B973-851EC67DC7DDQ33798359-FE7D075A-A946-4AAA-B993-28FE2C4A1733Q33896649-201B64F1-1143-4A06-9FFC-5ECDB85AFC41Q34005738-93A9874C-FA65-46A8-BF57-69B7EA9801F2Q34036341-C8ADAF04-C2D2-4A57-B9A2-C8CE5530080CQ35175958-F55716E8-F56F-4FC1-95A4-8417331B9A0DQ36326247-9ED47B89-F846-4424-8A7D-D50EF5614132Q36740729-A3084F46-BC0B-4799-AC1C-154FC0FF09B5Q37085601-40EED1D3-8D8D-4724-A375-40DF79B79C84Q37309967-92B4FF40-EADF-444C-B202-1D4AD116F925Q37329859-8D9482AA-FCB6-43EC-863B-8749ADDABA25Q37486527-4042ED23-1929-41BC-ABCB-CCB04D5D2610Q37977169-2AECE059-BDA3-4B50-9F66-4A064C92374AQ41308090-565510C1-14BD-4937-B990-DA78AAF2BE45Q44573252-43F9374E-29BC-4FE1-A221-4EAC93C6F654Q48160590-5C1BD55C-6463-469F-802E-61F2FF6087AEQ54594575-511CD033-34C4-4ABB-9FA2-792EB8571F6E
P2860
Targeted deletion of MKK4 in cancer cells: a detrimental phenotype manifests as decreased experimental metastasis and suggests a counterweight to the evolution of tumor-suppressor loss.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Targeted deletion of MKK4 in c ...... tion of tumor-suppressor loss.
@en
type
label
Targeted deletion of MKK4 in c ...... tion of tumor-suppressor loss.
@en
prefLabel
Targeted deletion of MKK4 in c ...... tion of tumor-suppressor loss.
@en
P2093
P1433
P1476
Targeted deletion of MKK4 in c ...... tion of tumor-suppressor loss.
@en
P2093
David A Dezentje
Eike Gallmeier
Eric S Calhoun
Geppino Falco
Kotb Abdelmohsen
Scott E Kern
Steven C Cunningham
Tomas Hucl
P304
P356
10.1158/0008-5472.CAN-06-0555
P407
P577
2006-06-01T00:00:00Z